Webinar Series: Data and Science of the COVID-19 Vaccines with Experts in Science and Medicine

View this exciting conversation about the data and science of the Covid-19 vaccines with Dr. Chris Martenson and Dr. Paul Alexander.

Dr. Chris Martenson has a PhD from Duke University (Pathology/Toxicology) and an MBA from Cornell. After being a scientist for 7 years, he worked in corporate finance for Pfizer and then as VP of SAIC. He is a published scientist, and now a successful entrepreneur.

His expertise spans toxicology, biology, financial markets and monetary policy, strategic and critical thinking, and influential communication.

His current mission is “Rescuing the future by empowering resilience” which he accomplishes by creating transformative content for a global audience.

In 2008 he launched The Crash Course, a 4 hour long on-line video series, that became a viral sensation with millions of views that was translated into 12 languages. The core of his work takes a ‘systems approach’ which offers insights into our future by aligning and spanning the diverse fields of economy, energy & the environment. His more recent Covid-19 coverage garnered many tens of millions of views in 2020 & 2021 positively influencing countless lives by providing essential information that was actionable.

His company, Peak Prosperity, LLC, now operates a diverse set of distribution platforms centered around his website, peakproperity.com, and has 500,000+ subscribers across multiple channels.

Dr. Paul E. Alexander, an esteemed epidemiologist and a widely recognized global expert on COVID-19, is chief scientific officer of the Unity Project. He has previously served as senior advisor to the assistant secretary of the U.S. Department of Health and Human Services specializing in COVID pandemic policy during the Trump administration. Dr. Alexander has also worked with the World Health Organization/Pan American Health Organization as a COVID pandemic evidence-synthesis advisor and is a former assistant professor at McMaster University in evidence-based medicine and research

Skip to content